NO151240C - Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler

Info

Publication number
NO151240C
NO151240C NO782813A NO782813A NO151240C NO 151240 C NO151240 C NO 151240C NO 782813 A NO782813 A NO 782813A NO 782813 A NO782813 A NO 782813A NO 151240 C NO151240 C NO 151240C
Authority
NO
Norway
Prior art keywords
nitroimidazoles
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO782813A
Other languages
English (en)
Other versions
NO782813L (no
NO151240B (no
Inventor
Carey Ernest Smithen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO782813L publication Critical patent/NO782813L/no
Publication of NO151240B publication Critical patent/NO151240B/no
Publication of NO151240C publication Critical patent/NO151240C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO782813A 1977-08-19 1978-08-18 Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler NO151240C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3490877 1977-08-19
GB1953478 1978-05-15

Publications (3)

Publication Number Publication Date
NO782813L NO782813L (no) 1979-02-20
NO151240B NO151240B (no) 1984-11-26
NO151240C true NO151240C (no) 1985-03-06

Family

ID=26254111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782813A NO151240C (no) 1977-08-19 1978-08-18 Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler

Country Status (26)

Country Link
US (1) US4241060A (no)
EP (1) EP0000928B1 (no)
JP (1) JPS5444671A (no)
AR (3) AR218325A1 (no)
AT (1) AT364829B (no)
AU (1) AU516443B2 (no)
CA (1) CA1104133A (no)
DE (2) DE2836073A1 (no)
DK (1) DK155367C (no)
ES (3) ES472661A1 (no)
FI (1) FI70576C (no)
FR (1) FR2400512A1 (no)
GB (1) GB2003154A (no)
GR (1) GR73055B (no)
HU (1) HU179983B (no)
IE (1) IE47132B1 (no)
IL (1) IL55351A (no)
IT (1) IT1098042B (no)
MC (1) MC1210A1 (no)
NL (1) NL7808597A (no)
NO (1) NO151240C (no)
NZ (1) NZ188140A (no)
PH (1) PH16364A (no)
PT (1) PT68441A (no)
SE (1) SE7808773L (no)
YU (1) YU41317B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2948884A1 (de) * 1979-12-05 1981-06-11 Basf Ag, 6700 Ludwigshafen 2-hydroxypropylimidazole, verfahren zu ihrer herstellung und verwendung als oelloesliche korrosionsinhibitoren
ZW8781A1 (en) * 1980-05-23 1981-12-16 Hoffmann La Roche 2-nitroimidazoles and preparation thereof
US4494547A (en) * 1981-03-30 1985-01-22 North Carolina Central University 2H-isoindolediones, their synthesis and use as radiosensitizers
US4605744A (en) * 1982-03-18 1986-08-12 Hoffmann-La Roche Inc. Imidazole derivatives
US4537969A (en) * 1982-03-18 1985-08-27 Hoffmann-La Roche Inc. Imidazole derivatives
GB2123816B (en) * 1982-05-27 1986-03-19 Nat Res Dev Nitrolmidazole derivatives
CA1227211A (en) * 1982-05-27 1987-09-22 Israr Ahmed Nitro imidazolyl aziridino propanols
AU559559B2 (en) * 1982-08-17 1987-03-12 Suntech, Inc. Perfluorocarbon emulsions and their preparation and use in therapy
US4742050B1 (en) * 1982-08-17 1994-06-28 Alpha Therapeutic Corp Sensitization of hypoxic tumor cells and control of growth thereof
US4889525A (en) * 1982-08-17 1989-12-26 Adamantech, Inc. Sensitization of hypoxic tumor cells and control of growth thereof
US5304654A (en) * 1987-06-10 1994-04-19 Yasunori Nishijima Fluorine-containing nitroimidazole compounds
CA1329206C (en) * 1987-06-10 1994-05-03 Tsutomu Kagiya Fluorine-containing nitroazole derivatives and radiosensitizer comprising the same
JP2848602B2 (ja) * 1987-06-24 1999-01-20 京都大学長 新規含フッ素２−ニトロイミダゾールおよびそれを含む放射線増感剤
US4797397A (en) * 1987-07-31 1989-01-10 Warner-Lambert Company 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
ATE129703T1 (de) * 1987-12-04 1995-11-15 British Tech Group Nitro substituierte aromatische und heteroaromatische verbindungen für krebsbehandlungen.
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
US5086068A (en) * 1988-02-26 1992-02-04 Alberta Cancer Board Immunochemical detection of hypoxia in normal and tumor tissue
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US5036096A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
US5036089A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents
US5073639A (en) * 1988-11-25 1991-12-17 Warner-Lambert Company Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
JPH02146288A (ja) * 1988-11-25 1990-06-05 Ebara Corp 内部圧縮を持つ容積型圧縮機
JP2799368B2 (ja) * 1990-01-10 1998-09-17 ポーラ化成工業株式会社 抗原虫剤
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
WO1994011348A1 (en) * 1992-11-19 1994-05-26 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US6252087B1 (en) 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US5741800A (en) * 1993-06-22 1998-04-21 Knoll Aktiengesellachaft Azolyl-cyclic amine derivates with immunomodulatory activity
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US5972984A (en) * 1995-06-06 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
EP1838305A1 (en) * 2005-01-21 2007-10-03 Richard H. Matthews Radiosensitizer formulations comprising nitrohistidine derivatives
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
US7842278B2 (en) * 2006-10-27 2010-11-30 Natural Pharmacia International, Inc. Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
MD4150C1 (ro) * 2011-10-11 2012-09-30 Институт Химии Академии Наук Молдовы Procedeu de obţinere a compuşilor coordinativi ai Co(II), Ni(II) şi Zn(II) cu 2-nitro-4,5-difenilimidazol pornind de la 4,5-difenilimidazol şi nitraţii metalelor respective
MD4178C1 (ro) * 2012-02-27 2013-02-28 Институт Химии Академии Наук Молдовы Procedeu de obţinere a 2-nitro-4,5-difenilimidazolului
JP2016525059A (ja) * 2013-07-16 2016-08-22 コーニング インコーポレイテッド 薄ガラスを曲げるための装置及び方法
CN108203411A (zh) * 2016-12-19 2018-06-26 曾舟华 一种高压合成甲硝唑的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA746007A (en) * 1966-11-08 W. Henry David 1-substituted-2-sulfonyl-5-nitroimidazoles
US3255201A (en) * 1965-04-09 1966-06-07 Hoffmann La Roche 2-nitroimidazoles
US3505349A (en) * 1966-04-18 1970-04-07 Hoffmann La Roche 2-nitro-imidazolyl-1-acetamides
CH513879A (de) * 1966-06-10 1971-10-15 Hoffmann La Roche Verfahren zur Herstellung von Imidazolderivaten
US3646057A (en) * 1969-04-06 1972-02-29 Hoffmann La Roche 2-nitroimidazoles
FR2260996A1 (en) * 1974-02-15 1975-09-12 Hoffmann La Roche (2-Nitro-1-imidazolyl)-carbamates - useful as germicides and antiproto-zoal agents
DE2410749A1 (de) * 1974-03-06 1975-09-11 Hoffmann La Roche 2-nitroimidazole
US4038410A (en) * 1974-03-14 1977-07-26 Schering Aktiengesellschaft Nitroimidazole derivatives and process for the preparation thereof

Also Published As

Publication number Publication date
AT364829B (de) 1981-11-25
AR220216A1 (es) 1980-10-15
ES478051A1 (es) 1979-10-16
DK366678A (da) 1979-02-20
NO782813L (no) 1979-02-20
FR2400512B1 (no) 1980-07-04
ATA601078A (de) 1981-04-15
FI782530A (fi) 1979-02-20
DK155367B (da) 1989-04-03
HU179983B (en) 1983-01-28
IE781453L (en) 1979-02-19
ES478052A1 (es) 1979-10-16
JPS5444671A (en) 1979-04-09
AU516443B2 (en) 1981-06-04
AR218325A1 (es) 1980-05-30
SE7808773L (sv) 1979-02-20
DE2860546D1 (en) 1981-04-16
NZ188140A (en) 1981-01-23
FI70576B (fi) 1986-06-06
NL7808597A (nl) 1979-02-21
DK155367C (da) 1989-08-14
US4241060A (en) 1980-12-23
PH16364A (en) 1983-09-08
JPS6220187B2 (no) 1987-05-06
ES472661A1 (es) 1979-02-16
YU41317B (en) 1987-02-28
MC1210A1 (fr) 1979-05-18
DE2836073A1 (de) 1979-03-01
YU195378A (en) 1983-01-21
IL55351A (en) 1982-07-30
GR73055B (no) 1984-01-26
IT1098042B (it) 1985-08-31
PT68441A (no) 1978-09-01
GB2003154A (en) 1979-03-07
EP0000928A1 (de) 1979-03-07
IE47132B1 (en) 1983-12-28
CA1104133A (en) 1981-06-30
FR2400512A1 (fr) 1979-03-16
AU3891578A (en) 1980-02-21
NO151240B (no) 1984-11-26
EP0000928B1 (de) 1981-03-18
AR218553A1 (es) 1980-06-13
IT7826792A0 (it) 1978-08-16
IL55351A0 (en) 1978-10-31
FI70576C (fi) 1986-09-24

Similar Documents

Publication Publication Date Title
NO151240C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
NO151461C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO148957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO149065C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.